Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.
about
Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homesEvaluation of the brief wisconsin inventory of smoking dependence motives in african-american and European-american heavy smokers.Prenatal tobacco exposure and cotinine in newborn dried blood spots.Intraindividual covariation between e-cigarette and combustible cigarette use in Korean American emerging adults.Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids--anatabine and anabasine--in smokers' urine.UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphismsNicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populationsUGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.Racial differences in CT phenotypes in COPD.Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumptionAncestral-derived effects on the mutational landscape of laryngeal cancer.Associations Between Genetic Ancestries and Nicotine Metabolism Biomarkers in the Multiethnic Cohort StudyAfrican ancestry, early life exposures, and respiratory morbidity in early childhood.Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes.Effects of aging on the effectiveness of smoking cessation medication.The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European AmericansN-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.Posttranscriptional regulation of UGT2B10 hepatic expression and activity by alternative splicing.
P2860
Q28389203-D34FC9EF-4844-41E8-8F4B-AE358D6A82A2Q30426991-9BC8FC6C-26DD-4DD6-A86D-F36C5BF66979Q33671993-C6FE9C7E-CE4F-486F-AD2C-99D309E4A5D7Q33836055-1B2D32E5-D53C-482C-AF04-4238C36E9898Q33889868-20CF053B-4AC0-46A0-B196-FC363927CF9DQ33903103-06948439-29B8-42A3-9A82-6AC86197D427Q34390412-68F724BB-4A50-42BC-9A2B-67FDF1AC9C55Q34434951-2DEC125A-83CA-4B74-82F8-28182A8260DAQ34926339-E2824D18-5451-4D2F-B75E-2C8FB9D05B0CQ34963910-21AE4CD6-352F-43B2-B68E-637F0E0DDB1EQ34964392-A8A9C73D-CF5B-4F04-B988-608419824860Q35064411-5D680D62-2803-49FD-BFE2-9D428174E667Q35099123-85C9FDD4-1551-4A3D-B759-5A39D16EB1FEQ35175672-870B67E1-BE9E-4B53-A1F9-0CA1A889313EQ35855468-B63E1CC4-320B-4B2B-B767-EAADE68BE4FAQ36093134-81B9BE06-2D59-41DA-BBA5-93021BAF0C86Q36600311-848CBAB9-E4A5-43C8-AC7E-7664E4292E87Q36722084-C1208342-BDF5-4FE4-AF89-DEF3072F9EDCQ36850983-F541013F-9892-461D-8ECE-44480D980CA0Q37215518-C4BDEC10-BFF5-447E-BDFE-A8F2A7AC4B0FQ37327407-6F8E1B77-B90F-4ADD-B5A8-4E1B156E915FQ37573962-B1AAEDC6-BC32-4894-9DD8-34CA8F96DFD4Q37857239-5DDE5E4A-28B4-4A21-AC0D-A2674DA07641Q41060193-744C6AF8-871F-424B-A0D2-1E7C32B5FD5FQ43585637-0E8927C2-9CA3-4920-AF63-CA59C12E7FA7Q46300070-B9AA5551-03C7-402F-93FF-C23247A8B247Q50024661-C0CD8B18-9712-4B05-B8EA-BE0CD28DAE68
P2860
Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@ast
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@en
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@nl
type
label
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@ast
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@en
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@nl
prefLabel
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@ast
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@en
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@nl
P2093
P2860
P356
P1476
Nicotine metabolism in African ...... hnicity and UGT2B10 haplotype.
@en
P2093
Angela J Boettcher
Dorothy K Hatsukami
Jeannette Zinggeler Berg
Jesse Mason
Sharon E Murphy
P2860
P304
P356
10.1124/JPET.109.159855
P407
P577
2009-09-28T00:00:00Z